The California Environmental Protection Agency extended the public comment period on the addition of imazalil and thiabendazole and its hypophosphite salt to the list of substances known to the state to cause cancer or reproductive toxicity. The new deadline is October 8, 2008. http://www.oal.ca.gov/pdfs/notice/31z-2008.pdf p. 1354.